A Study of TPD3310 in Patients With Advanced Malignant Tumors

NCT07368127 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumors

Interventions

DRUG: TPD3310 injection

Sponsor

TAIBIDI PHARMACEUTICAL TECHNOLOGY(SHIJIAZHUANG) CO.,LTD.